SVT-15652
/ Laboratorios SALVAT
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 04, 2022
SVT-15652 Otic Solution for the Treatment of Otomycosis
(clinicaltrials.gov)
- P3 | N=201 | Completed | Sponsor: Salvat | Recruiting ➔ Completed
Trial completion • Otorhinolaryngology
August 04, 2022
CLEAR-2: SVT-15652 Otic Solution for the Treatment of Otomycosis.
(clinicaltrials.gov)
- P3 | N=193 | Completed | Sponsor: Salvat | Active, not recruiting ➔ Completed
Trial completion • Otorhinolaryngology
September 29, 2021
SVT-15652 Otic Solution for the Treatment of Otomycosis
(clinicaltrials.gov)
- P3; N=191; Recruiting; Sponsor: Salvat; Trial completion date: Jul 2021 ➔ Nov 2021; Trial primary completion date: Jul 2021 ➔ Oct 2021
Clinical • Trial completion date • Trial primary completion date • Otorhinolaryngology
September 29, 2021
SVT-15652 Otic Solution for the Treatment of Otomycosis.
(clinicaltrials.gov)
- P3; N=191; Active, not recruiting; Sponsor: Salvat; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Otorhinolaryngology
1 to 4
Of
4
Go to page
1